Publications by authors named "Pierre Fenaux"

100Publications

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Nat Med 2020 Aug 3. Epub 2020 Aug 3.

Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41591-020-1008-zDOI Listing
August 2020

Which lower risk myelodysplastic syndromes should be treated with allogeneic hematopoietic stem cell transplantation?

Leukemia 2020 Jul 13. Epub 2020 Jul 13.

Service d'hématologie-sénior, hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) and Université de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0967-xDOI Listing
July 2020

Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.

Br J Haematol 2020 May 9;189(4):e133-e137. Epub 2020 Mar 9.

MDS Research Group, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16558DOI Listing
May 2020

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.

N Engl J Med 2020 01;382(2):140-151

From Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris (P.F., L.A.), Service des Maladies du Sang, Hôpital Huriez, Centre Hospitalier Universitaire (CHU) de Lille, Lille (B.Q.), the Department of Internal Medicine, CHU Toulouse, Institut Universitaire du Cancer de Toulouse, Toulouse (O.B.-R.), and Université Cote d'Azur, Département d'Hématologie Clinique, CHU Nice, Nice (T.C.) - all in France; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig (U.P.), Klinik für Hämatologie, Onkologie, and Klinische Immunologie, Universitätsklinik Düsseldorf, Düsseldorf (U.G.), and Klinik und Poliklinik für Innere Medizin III, Technische Universität München, Munich (K.S.G.) - all in Germany; the Department of Haemato-Oncology, King's College London, London (G.J.M.), Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford (P.V.), and the Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds (D.B.) - all in the United Kingdom; the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston (G.G.-M.); Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto (R.B.); MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence (V.S.), the Department of Oncology and Hematology, S. Orsola-Malpighi University Hospital, Bologna (C.F.), the University of Pavia, Fondazione IRCCS Policlinico S. Matteo, Pavia (M.C.), the Hematology Unit, Santi Antonio e Biagio e Cesare Arrigo Hospital, Alessandria (F.S., V.G.), and Dipartimento Biomedicina e Prevenzione, University of Rome Tor Vergata, Rome (M.-T.V.) - all in Italy; the Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca, Salamanca (M.D.-C.), Unidad de Hematología, Hospital Universitario Virgen del Rocío, Seville (J.F.F.), and the Department of Hematology, Hospital Universitario Cruces, Vizcaya (B.A.) - all in Spain; the Department of Hematology Science, School of Medicine, Ankara University, Ankara, Turkey (O.I.); the Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland (M.A.S.); the Department of Hematology, Algemeen Ziekenhuis Sint-Jan, Bruges (D.S.), and Universitair Ziekenhuis Gent, Ghent (D.M.) - both in Belgium; the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (A.E.D.); the Division of Hematology-Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center (J.G.J.), and Albert Einstein College of Medicine (A.V.) - both in New York; the Department of Hematology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands (E.V.); Stanford University Cancer Center, Stanford, CA (P.L.G.); the Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm (E.H.-L.); the Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT (A.M.Z.); Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville (M.R.S.); Celgene, Summit, NJ (A.L., J.Z., A.R., D.R.D.); Celgene International, Boudry, Switzerland (A.B.); Acceleron Pharma, Cambridge, MA (P.G.L., M.L.S.); and Moffitt Cancer Center, Tampa, FL (R.S.K., A.F.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1908892DOI Listing
January 2020

Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review.

Autoimmun Rev 2020 Feb 13;19(2):102446. Epub 2019 Dec 13.

Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France Sorbonne Université, France; Sorbonne Universités, INSERM U938, Centre de Recherche Saint-Antoine (CRSA), Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2019.102446DOI Listing
February 2020

How we manage adults with myelodysplastic syndrome.

Br J Haematol 2020 Jun 30;189(6):1016-1027. Epub 2019 Sep 30.

service d'hématologie séniors, hôpital St Louis, assistance publique - hôpitaux de Paris (APHP) and Université de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16206DOI Listing
June 2020

Non-allogeneic immunotherapy in acute myeloid leukaemia.

Lancet Haematol 2019 09 7;6(9):e443-e444. Epub 2019 Aug 7.

Hôpital Saint Louis, Assistance publique Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France; INSERM U944, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30159-0DOI Listing
September 2019

Guadecitabine in myelodysplastic syndromes: promising but there is still progress to be made.

Lancet Haematol 2019 06 3;6(6):e290-e291. Epub 2019 May 3.

Hopital Saint Louis and INSERM U944, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30079-1DOI Listing
June 2019

Autoantibodies in myelodysplastic syndromes and chronic myelomonocytic leukemia.

Leuk Lymphoma 2019 10 8;60(10):2594-2596. Epub 2019 Apr 8.

Sorbonne University, Internal Medicine Department, Saint Antoine Hospital , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1599114DOI Listing
October 2019

Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.

Leuk Res 2019 02 28;77:8-13. Epub 2018 Dec 28.

University of Rochester Medical Center, Department of Pathology, Hematopathology Unit and James P. Wilmot Cancer Institute, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.12.012DOI Listing
February 2019

Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis.

Blood 2019 02 2;133(8):790-794. Epub 2019 Jan 2.

Medical Clinic and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-11-876888DOI Listing
February 2019

Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review.

Br J Haematol 2019 01 13;184(2):134-160. Epub 2018 Dec 13.

Service d'Hématologie Clinique, Hôpital St. Louis and Paris 7 University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15707DOI Listing
January 2019

Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study.

Eur J Haematol 2019 Jan 14;102(1):63-69. Epub 2018 Nov 14.

Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13174DOI Listing
January 2019

Association between health literacy, communication and psychological distress among myelodysplastic syndromes patients.

Leuk Res 2018 10 5;73:44-50. Epub 2018 Sep 5.

Aix-Marseille Univ, APHM, INSERM, IRD, SESSTIM, "Cancer, Biomedicine & Society" Group, Hop Timone, BIOSTIC, Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.08.020DOI Listing
October 2018

Autoimmune manifestations associated with myelodysplastic syndromes.

Ann Hematol 2018 Nov 8;97(11):2015-2023. Epub 2018 Aug 8.

Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3472-9DOI Listing
November 2018

Molecular remission as a therapeutic objective in acute promyelocytic leukemia.

Leukemia 2018 08 19;32(8):1671-1678. Epub 2018 Jul 19.

Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0219-5DOI Listing
August 2018

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.

Nat Commun 2018 05 24;9(1):2047. Epub 2018 May 24.

INSERM U944, Equipe Labellisée par la Ligue Nationale contre le Cancer, Institut Universitaire d'Hématologie (IUH), 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-04384-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967331PMC
May 2018

A decade of progress in myelodysplastic syndrome with chromosome 5q deletion.

Leukemia 2018 07 30;32(7):1493-1499. Epub 2018 Jan 30.

Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris Université Paris 7, Paris, France.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41375-018-0029-9
Publisher Site
http://dx.doi.org/10.1038/s41375-018-0029-9DOI Listing
July 2018

The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study.

Clin Lymphoma Myeloma Leuk 2018 02 30;18(2):136-144.e7. Epub 2017 Dec 30.

Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.12.004DOI Listing
February 2018

Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.

Ann Hematol 2018 Mar 23;97(3):541-542. Epub 2017 Nov 23.

Hopital Saint Louis and Paris 7 university, 1 avenue Claude Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3190-8DOI Listing
March 2018

Myelodysplastic Syndrome and Giant Cell Arteritis: A Nonfortuitous Association that Geriatricians Should Know About.

J Am Geriatr Soc 2017 10 14;65(10):2335-2337. Epub 2017 Aug 14.

Department of Geriatrics, Unit of Peri-Operative Geriatric Care, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgs.15040
Publisher Site
http://dx.doi.org/10.1111/jgs.15040DOI Listing
October 2017

Azacitidine in adult patients with acute myeloid leukemia.

Crit Rev Oncol Hematol 2017 Aug 3;116:159-177. Epub 2017 Jun 3.

Hôpital Saint Louis, Institut Universitaire d'Hématologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.05.010DOI Listing
August 2017

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML.

Blood 2017 08 13;130(6):832-835. Epub 2017 Jun 13.

Département d'Hématologie et Immunologie Biologiques, Hôpitaux Universitaires Henri Mondor APHP, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-04-779579DOI Listing
August 2017

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

J Clin Oncol 2017 May 28;35(14):1591-1597. Epub 2017 Mar 28.

Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d'Angers; Sylvain Thépot, Université d'Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP, Université Paris V, Paris; Charikleia Kelaidi, CHU Avicenne, Avicenne; Odile Beyne-Rauzy, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Agnès Guerci-Bresler, CHU Nancy, Nancy; Dominique Bordessoule, CHU Dupuytren, Limoges; Pascale Cony-Makhoul, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy; Stéphane Cheze, CHU de Caen, Caen; Eric Wattel, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon; Christian Rose, Université Catholique de Lille, Lille; Norbert Vey, Institut Paoli-Calmettes Marseille, Marseille, France; Maria Diez Campelo, Hospital Universitario de Salamanca, Salamanca; Teresa Bernal, Hospital Central de Asturias, Oviedo; Fernando Ramos, Hospital de León, León; Marisa Calabuig, Hospital Clínico de Valencia; Guillermo F. Sanz, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Valeria Santini and Alessandro Sanna, Azienda Ospedaliero Universitaria (AOU) Careggi and University of Florence, Florence; Enrico Balleari, Istituto di Ricovero e Cura a Carattere Scientifico AOU San Martino di Genova, Genova; Daniela Gioia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria; Dario Ferrero, Università degli Studi di Torino; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Torino; Giovanni Cametti, Ospedale Maggiore di Chieri, Chieri; Fabrizio Pane, Università Federico II, Napoli, Italy; Mikkael A. Sekeres and Jaime Fensterl, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Rami Komrokji, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David P. Steensma, Dana-Farber Cancer Institute, Boston, MA; Gail J. Roboz, Weill Medical College of Cornell University, New York, NY; Jennifer Kaivers and Ulrich Germing, University of Düsseldorf, Düsseldorf; Katharina Götze and Catharina Müller-Thomas, Universität München, München, Germany; and Ioannis Kotsianidis, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3271DOI Listing
May 2017